IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Intellia Therapeutics Inc COM

CUSIP: US45826J1 | 1 institutional holders

Quarters

Q4 2024Q3 2024
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2024

Orchard Capital Management, LLC182,750
0.8% of portfolio›$2.1M
StyleTurnoverLocationFiled
Orchard Capital Management, LLC
182,750$2.1M0.8%Deep ValueMediumChicago, IL2025-02-14